Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach

Agriculture & Biology

• prostatic neoplasms 88%
• respiratory tract diseases 70%
• drug therapy 64%
• cohort studies 19%
• health insurance 14%
• beta-adrenergic agonists 12%
• calibration 8%
• antagonists 8%
• alcohol drinking 6%
• relative risk 6%
• body mass index 5%
• aspirin 5%

Medicine & Life Sciences

• Chronic Obstructive Pulmonary Disease 57%
• Prostatic Neoplasms 51%
• Databases 39%
• Drug Therapy 38%
• Muscarinic Antagonists 11%
• Propensity Score 9%
• Health Insurance 9%
• Calibration 9%
• Cohort Studies 9%

Chemical Compounds

• Muscarinic Antagonist 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 46%